세계의 전문 의료영상 저장 전송 시스템(PACS) 시장 - 규모, 점유율, 동향 분석 보고서 : 전문별, 전개 모드별, 최종 용도별, 지역별 부문 예측(2025-2033년)

Specialty PACS Market Summary

The global specialty picture archiving and communication system market size was estimated at USD 3.74 billion in 2024 and is projected to reach USD 6.57 billion by 2033, growing at a CAGR of 6.6% from 2025 to 2033. This growth is attributed to rising adoption of digital imaging solutions, the increasing volume of medical imaging procedures, growing demand for tele radiology and remote diagnostics, Government initiatives and regulatory support for healthcare IT adoption, and Technological advancements in cloud-based PACS solutions.

Moreover, the growing integration of artificial intelligence (AI) into specialty PACS is an emerging trend shaping the market. The increasing volume of medical imaging procedures is a major driver for the specialty (Picture Archiving And Communication System) PACS industry. The growth is fueled by the rising prevalence of chronic diseases, an aging population, and advances in imaging modalities that expand diagnostic capabilities. As more scans are performed across specialties such as cardiology, mammography, orthopedics, and dentistry, healthcare providers face growing challenges in storing, retrieving, and managing large volumes of complex image data. According to the Journal of the American College of Radiology, imaging utilization is projected to rise from 16.9% in 2023 to 26.9% by 2055, highlighting the accelerating demand for efficient imaging management systems which further emphasizes the need for specialty PACS solutions that offer tailored workflows, advanced visualization, and streamlined data management to enable faster interpretation, improved collaboration, and better patient outcomes.

Rising adoption of tele radiology is driving growth in the specialty PACS market, as healthcare providers increasingly rely on remote diagnostic services to address radiologist shortages, expand access to expertise, and enable around-the-clock reporting. According to Merative, by 2033, the U.S. could face a shortage of up to 42,000 radiologists. Tele radiology allows medical images from modalities such as CT, MRI, mammography, and ultrasound to be shared instantly across locations, supporting faster diagnoses and continuity of care, particularly in rural or underserved regions. Specialty PACS solutions complement this demand by offering cloud-based access, secure image sharing, and specialty-specific workflows that ensure seamless collaboration between radiologists and referring physicians across geographies, improving efficiency, turnaround times, and diagnostic accuracy.

Global Specialty PACS Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global specialty PACS market report based on specialty, deployment mode, end use, and region:

• Specialty Outlook (Revenue, USD Million, 2021 - 2033)
• Radiology PACS
• Cardiology PACS
• Mammography PACS
• Orthopedic PACS
• Ophthalmology PACS
• Pathology PACS
• Oncology / Radiation Therapy PACS
• Others
• Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
• Cloud-Based/ Web-Based
• On-premise
• Hybrid
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Diagnostic Imaging Centers
• Telemedicine & Tele radiology Providers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Specialty
  • 1.2.2. Deployment Mode
  • 1.2.3. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising adoption of digital imaging solutions
    • 3.2.1.2. Increasing volume of medical imaging procedures
    • 3.2.1.3. Expanding remote access and telemedicine adoption
    • 3.2.1.4. Growing demand for specialty-specific imaging
    • 3.2.1.5. Increasing integration with EHR/EMR and RIS systems
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High implementation and maintenance costs
    • 3.2.2.2. Data privacy and security concerns
    • 3.2.2.3. Limited availability of skilled workforce to operate and manage PACS
    • 3.2.2.4. Complex and varying regulatory requirements across regions
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Technology Overview
    • 3.2.5.1. AI & Machine Learning
    • 3.2.5.2. 3D Visualization & Reconstruction
    • 3.2.5.3. Automated Workflow & Reporting Tools
    • 3.2.5.4. Cloud Storage & Remote Access
  • 3.2.6. Company-Level Security & Compliance Overview
  • 3.2.7. Case Studies
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. Specialty PACS Market: Specialty Estimates & Trend Analysis

• 4.1. Specialty Segment Dashboard
• 4.2. Specialty Market Share Movement Analysis, 2024 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Specialty, 2021 to 2033 (USD Million)
• 4.4. Radiology PACS
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Cardiology PACS
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Mammography PACS
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Orthopedic PACS
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Ophthalmology PACS
  • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Pathology PACS
  • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Oncology / Radiation Therapy PACS
  • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Others
  • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Specialty PACS Market: Deployment Mode Estimates & Trend Analysis

• 5.1. Deployment Mode Dashboard
• 5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
• 5.4. Cloud-Based/ Web-Based
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. On-Premise
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Hybrid
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Specialty PACS Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. End Use Market Share Movement Analysis, 2024 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Specialty Clinics
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Diagnostic Imaging Centers
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Telemedicine & Tele radiology Providers
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Specialty PACS Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market: Key Takeaways
• 7.3. North America
  • 7.3.1. North America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive insights
    • 7.3.2.4. U.S. Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive insights
    • 7.3.3.4. Canada Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive insights
    • 7.3.4.4. Mexico Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. Germany Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. UK Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. France Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive insights
    • 7.4.5.4. Italy Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive insights
    • 7.4.6.4. Spain Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive insights
    • 7.4.7.4. Denmark Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive insights
    • 7.4.8.4. Sweden Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive insights
    • 7.4.9.4. Norway Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. Japan Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. China Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. India Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. South Korea Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Australia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Thailand Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Specialty PACS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Brazil Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. Argentina Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. South Africa Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Saudi Arabia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive insights
    • 7.7.4.4. UAE Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive insights
    • 7.7.5.4. Kuwait Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis/Company Market Share Analysis (2024)
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Novarad
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. INFINITT North America Inc.
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Sectra AB
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. Intelerad
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. Koninklijke Philips N.V.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. GE HealthCare
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. FUJIFILM Corporation
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Canon Medical Systems, USA.
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Agfa HealthCare
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Merative
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Ramsoft
    • 8.5.11.1. Overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Optum, Inc.
    • 8.5.12.1. Overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Siemens Healthineers AG
    • 8.5.13.1. Overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Medstrat
    • 8.5.14.1. Overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Candelis Corporation
    • 8.5.15.1. Overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. Phoenix Ortho
    • 8.5.16.1. Overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product benchmarking
    • 8.5.16.4. Strategic initiatives